Literature DB >> 17204373

Orbitofrontal cortex lesions disrupt risk assessment in a novel serial decision-making task for rats.

M Pais-Vieira1, D Lima, V Galhardo.   

Abstract

Neurobiological mechanisms of decision-making have been shown to be modulated by a number of frontal brain regions. Among those areas, the orbitofrontal cortex (OFC) is thought to play an important role in the decision of behavioral actions when faced with alternative options of ambiguous outcome. Here we present a novel neurobehavioral task to study affective decision-making in the rat, based on evaluation of consecutive choices between two levers associated with rewards of different value and probability. Two groups of animals were studied; a sham control group (n=6) and an OFC-lesioned group (n=7). In the first 30 trials both groups had similar preference patterns but at the end of the 90 trials of the task both groups developed specific preferences. The control group systematically preferred the lever associated with smaller but more reliable rewards (low risk lever) while the OFC lesion group preferred the high risk lever (index of preference of 0.21+/-0.21 vs. -0.45+/-0.10; t-test, P<0.05). Analysis of choice persistence (i.e. choosing the same lever in consecutive trials) suggests that the OFC-lesioned group became less sensitive to risk, seeking large rewards irrespective of their success probability.

Entities:  

Mesh:

Year:  2007        PMID: 17204373     DOI: 10.1016/j.neuroscience.2006.11.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

1.  Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder.

Authors:  Michael D De Bellis; Lihong Wang; Sara R Bergman; Richard H Yaxley; Stephen R Hooper; Scott A Huettel
Journal:  Drug Alcohol Depend       Date:  2013-06-14       Impact factor: 4.492

2.  Neurons in rat orbitofrontal cortex and medial prefrontal cortex exhibit distinct responses in reward and strategy-update in a risk-based decision-making task.

Authors:  Dan-Dan Hong; Wen-Qiang Huang; Ai-Ai Ji; Sha-Sha Yang; Hui Xu; Ke-Yi Sun; Aihua Cao; Wen-Jun Gao; Ning Zhou; Ping Yu
Journal:  Metab Brain Dis       Date:  2018-12-08       Impact factor: 3.584

3.  Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors.

Authors:  Guangchen Ji; Volker Neugebauer
Journal:  J Neurophysiol       Date:  2011-08-31       Impact factor: 2.714

4.  Dissociable roles for the basolateral amygdala and orbitofrontal cortex in decision-making under risk of punishment.

Authors:  Caitlin A Orsini; Rose T Trotta; Jennifer L Bizon; Barry Setlow
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

5.  mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making.

Authors:  Hao Sun; Volker Neugebauer
Journal:  J Neurophysiol       Date:  2011-05-25       Impact factor: 2.714

6.  Risk-preference differentiates orbitofrontal cortex responses to freely chosen reward outcomes.

Authors:  Jamie D Roitman; Mitchell F Roitman
Journal:  Eur J Neurosci       Date:  2010-04-09       Impact factor: 3.386

7.  Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.

Authors:  Guangchen Ji; Hao Sun; Yu Fu; Zhen Li; Miguel Pais-Vieira; Vasco Galhardo; Volker Neugebauer
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

Review 8.  What the orbitofrontal cortex does not do.

Authors:  Thomas A Stalnaker; Nisha K Cooch; Geoffrey Schoenbaum
Journal:  Nat Neurosci       Date:  2015-05       Impact factor: 24.884

Review 9.  Neural mechanisms of pain and alcohol dependence.

Authors:  A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan
Journal:  Pharmacol Biochem Behav       Date:  2013-10-02       Impact factor: 3.533

Review 10.  [Chronic pain : Perception, reward and neural processing].

Authors:  S Becker; M Diers
Journal:  Schmerz       Date:  2016-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.